- Home
- CMPX vs GDEV Comparison
CMPX vs GDEV Comparison
Compare CMPX & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- GDEV
- Stock Information
- Founded
- CMPX 2014
- GDEV 2009
- Country
- CMPX United States
- GDEV Cyprus
- Employees
- CMPX N/A
- GDEV N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- GDEV EDP Services
- Sector
- CMPX Health Care
- GDEV Technology
- Exchange
- CMPX Nasdaq
- GDEV Nasdaq
- Market Cap
- CMPX 291.8M
- GDEV 266.7M
- IPO Year
- CMPX N/A
- GDEV N/A
- Fundamental
- Price
- CMPX $3.44
- GDEV $14.53
- Analyst Decision
- CMPX Strong Buy
- GDEV Buy
- Analyst Count
- CMPX 8
- GDEV 1
- Target Price
- CMPX $13.50
- GDEV $70.00
- AVG Volume (30 Days)
- CMPX 1.4M
- GDEV 5.3K
- Earning Date
- CMPX 08-11-2025
- GDEV 09-02-2025
- Dividend Yield
- CMPX N/A
- GDEV N/A
- EPS Growth
- CMPX N/A
- GDEV 12.96
- EPS
- CMPX N/A
- GDEV 2.56
- Revenue
- CMPX N/A
- GDEV $425,112,000.00
- Revenue This Year
- CMPX N/A
- GDEV N/A
- Revenue Next Year
- CMPX N/A
- GDEV $11.69
- P/E Ratio
- CMPX N/A
- GDEV $5.68
- Revenue Growth
- CMPX N/A
- GDEV N/A
- 52 Week Low
- CMPX $1.27
- GDEV $8.60
- 52 Week High
- CMPX $4.08
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- CMPX 62.85
- GDEV 50.66
- Support Level
- CMPX $3.29
- GDEV $11.25
- Resistance Level
- CMPX $3.52
- GDEV $17.00
- Average True Range (ATR)
- CMPX 0.18
- GDEV 1.01
- MACD
- CMPX 0.04
- GDEV 0.27
- Stochastic Oscillator
- CMPX 81.68
- GDEV 57.04
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.